The report “Platelet Aggregation Devices Market by Product (Systems, Reagents, Consumables, Accessories), Application (Research, Diagnostic, CVD, Orthopedic, Trauma), End User (Hospitals, Diagnostic Laboratories, Academia, Blood Banks) - Global Forecasts to 2020, the Global Platelet Aggregation Devices Market Is Poised to Reach $342.4 Million by 2020, Growing at a CAGR of 21.0% from 2015 to 2020.
Browse 71 tables and 40 figures spread through 137 pages and in-depth TOC on "Platelet Aggregation Devices Market"
Early buyers will receive 10% customization on this report.
This report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
On the basis of products, the global platelet aggregation devices market is classified into three major segments, namely, systems, reagents, and consumables & accessories. On the basis of applications, the global platelet aggregation devices market is classified into research applications and clinical applications. The clinical applications segment is further classified into three subsegments, namely, cardiovascular, orthopedic, and other clinical applications (includes monitoring of antiplatelet therapy and urology, trauma, and bleeding disorders).
Get The PDF Brochure For This Report:
Factors such as rising incidences of target diseases, rapid growth in the geriatric population across the globe, technological advancements in platelet aggregometers, and increasing number of industry-academia collaborations and clinical studies are fuelling the growth of the global platelet aggregation devices market. On the other hand, procedural limitations, unfavorable healthcare reforms in the U.S., and dearth of well trained and skilled professionals are some of the key factors hampering the growth of this market.
As of 2015, North America is expected to hold the largest share of the platelet aggregation devices market, followed by Europe. Additionally, North America is expected to grow at the highest CAGR during the forecast period (2015 to 2020). Strong market growth witnessed in the North American platelet aggregation devices market can be attributed to factors such as large patient population for target diseases; strong presence of device manufacturers in the region; growing number of surgical procedures; rising awareness among healthcare professionals (regarding the benefits offered by platelet aggregation testing in disease diagnosis); large number of patients undergoing cardiovascular surgeries; and increasing prevalence of orthopedic, urological, and bleeding disorders.
Talk To Our Research Analysts for More Information:
F. Hoffmann La-Roche Ltd. (Switzerland), Haemonetics Corporation (U.S.), Sysmex Corporation (Japan), Siemens AG (Germany), Accriva Diagnostics (U.S.), Helena Laboratories Corporation (U.S.), Bio/Data Corporation (U.S.), Tem Group (Switzerland), Sentinel CH. S.p.A. (Italy), and Aggredyne, Inc. (U.S.) are the major players in the global platelet aggregation devices market.
Browse Related Reports:
Hematology Analyzers & Reagents Market - by Products (3-& 5- part hematology Analyzers, Point-of-Care, & Fully Automated), Consumables (Reagents & Stains), End Users (Research Institute, Hospital, & Clinical Testing Labs) - Global Forecasts to 2019.
Coagulation/Hemostasis Analyzer Market - by Product (Automated, POC), Consumables (Reagents, Standards), Test Type (APTT, Prothrombin Time/INR, D-Dimer, Fibrinogen), Technology (Mechanical, Optical), End Users (Research Institutes, Hospitals) - Forecast to 2019.
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html
1 South Dearborn Street,
21st Floor, Chicago,
Illinois, 60603, United States,
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnologyConnect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets